§ 2604. Reimbursement by third-party payers. Blood lead testing, screening, screening-related services, and diagnostic evaluations as required by § 2602 of this title are reimbursable under health insurance contracts and group and blanket health insurance under §§ 3337 and 3554 of Title 18, respectively.69 Del. Laws, c. 310, § 1; 83 Del. Laws, c. 75, § 4;
Reimbursement by third-party payers.
16 Del. C. § 2604., under Childhood Lead Poisoning Prevention Act.
16 Del. C. § 2604.